1. P01.150 hypermutations in glioblastoma are associated with increased response to immunotherapy. (19th September 2018) Authors: Anghileri, E; Zhao, J; Eoli, M; Langella, T; Pollo, B; Indraccolo, S; Pellegatta, S; Iavarone, A; Rabadan, R; Finocchiaro, G Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P02.06 De-novo ceramide synthesis in skull base chordomas suggests a correlation with tumor proliferation. (19th September 2018) Authors: La Corte, E; Patanè, M; Calatozzolo, C; Maderna, E; Raggi, A; Dei Cas, M; Paroni, R; Ghidoni, R; Ferroli, P; Pollo, B Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P02.06 De-novo ceramide synthesis in skull base chordomas suggests a correlation with tumor proliferation. (19th September 2018) Authors: La Corte, E; Patanè, M; Calatozzolo, C; Maderna, E; Raggi, A; Dei Cas, M; Paroni, R; Ghidoni, R; Ferroli, P; Pollo, B Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001). (6th September 2019) Authors: Gentner, B; Ciceri, F; DiMeco, F; Legnani, F; Eoli, M; Pollo, B; Farina, F; Mazzoleni, S; Russo, C; Naldini, L; Finocchiaro, G Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P05.45 Hydroxyurea (HU) or VAC (vincristine, adriamycin and cyclophosphamide) in a group of recurrent meningioma patients. (19th September 2018) Authors: Silvani, A; Simonetti, G; Elena Antonia, L; Pollo, B; Fariselli, L; Gaviani, P Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P05.45 Hydroxyurea (HU) or VAC (vincristine, adriamycin and cyclophosphamide) in a group of recurrent meningioma patients. (19th September 2018) Authors: Silvani, A; Simonetti, G; Elena Antonia, L; Pollo, B; Fariselli, L; Gaviani, P Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P05.85 Mismatch repair system and immune-checkpoints profile in brain metastasis: study of 65 patients. (19th September 2018) Authors: Patanè, M; Calatozzolo, C; Farinotti, M; Cacciatore, F C; Silvani, A; Anghileri, E; DiMeco, F; Pollo, B Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P09.03 Array-CGH analysis in meningiomas adds further information of biological behavior. (6th September 2019) Authors: Calatozzolo, C; Rizzo, A; Girgenti, V; Saladino, A; Patanè, M; Di Meco, F; Pollo, B; Sciacca, F L Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P11.68.A Hemangiopericytoma, case series and clinic-pathological analysis. (5th September 2022) Authors: Redaelli, V; Calatozzolo, C; Marucci, G; Pinzi, V; Gaviani, P; Botturi, A; Simonetti, G; Mattei, L; Pollo, B; Silvani, A Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses. (12th March 2014) Authors: Pellegatta, S; Eoli, M; Bruzzone, MG; Cuzzubbo, S; Anghileri, E; Antozzi, C; Frigerio, S; Pollo, B; Parati, EA; Finocchiaro, G Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗